These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9067810)

  • 1. The formulation of drug for ocular administration.
    Aiache JM; el Meski S; Beyssac E; Serpin G
    J Biomater Appl; 1997 Jan; 11(3):329-48. PubMed ID: 9067810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular preparations: the formulation approach.
    Kaur IP; Kanwar M
    Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
    Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
    Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery.
    Kaur IP; Smitha R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):353-69. PubMed ID: 12056529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of ocular drug penetration.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Crit Rev Ther Drug Carrier Syst; 1999; 16(1):85-146. PubMed ID: 10099899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
    Babizhayev MA
    Drug Test Anal; 2012 Jun; 4(6):468-85. PubMed ID: 21416634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular drug delivery.
    Ghate D; Edelhauser HF
    Expert Opin Drug Deliv; 2006 Mar; 3(2):275-87. PubMed ID: 16506953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An updated patent review on ocular drug delivery systems with potential for commercial viability.
    Srivastava R; Pathak K
    Recent Pat Drug Deliv Formul; 2011 May; 5(2):146-62. PubMed ID: 21453249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination.
    Kalam MA; Alshamsan A; Aljuffali IA; Mishra AK; Sultana Y
    Drug Deliv; 2016; 23(3):896-907. PubMed ID: 24865289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review.
    Dubald M; Bourgeois S; Andrieu V; Fessi H
    Pharmaceutics; 2018 Jan; 10(1):. PubMed ID: 29342879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of dosage forms: application of gamma scintigraphy to non-enteral routes of administration.
    Meseguer G; Gurny R; Buri P
    J Drug Target; 1994; 2(4):269-88. PubMed ID: 7858953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylboronic-Acid-Based Polymeric Micelles for Mucoadhesive Anterior Segment Ocular Drug Delivery.
    Prosperi-Porta G; Kedzior S; Muirhead B; Sheardown H
    Biomacromolecules; 2016 Apr; 17(4):1449-57. PubMed ID: 26963738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New vehicle based on a microemulsion for topical ocular administration of dexamethasone.
    Fialho SL; da Silva-Cunha A
    Clin Exp Ophthalmol; 2004 Dec; 32(6):626-32. PubMed ID: 15575833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterials for ocular drug delivery.
    Liu S; Jones L; Gu FX
    Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to glaucoma drug delivery.
    Ghate D; Edelhauser HF
    J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colloidal drug delivery system: amplify the ocular delivery.
    Ali J; Fazil M; Qumbar M; Khan N; Ali A
    Drug Deliv; 2016; 23(3):710-26. PubMed ID: 24892625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.